|
May 10
|
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
|
|
May 8
|
Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
|
|
Aug 7
|
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
|
|
May 3
|
Inhibrx Stock Showing Improving Market Leadership; Earns 86 RS Rating
|
|
Apr 26
|
Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials
|